sur Aap Implantate AG (ETR:AAQ)
Aap Implantate AG Announces Management Board Changes
aap Implantate AG has announced a significant shift in its Management Board. Mr. Rubino Di Girolamo will step down from his roles as a board member and Chief Executive Officer effective December 31, 2026. His resignation has been agreed upon with the Supervisory Board and marks an early departure.
The Supervisory Board has swiftly appointed Mr. Cornelius Fink as a new member of the Executive Board. Fink will lead the Trauma division. Additionally, Ms. Nicole Kassel joins the Board of Management, assuming responsibility as the Chief Financial Officer.
This reshuffle indicates a strategic repositioning within the company, aiming to refine operational focus and enhance its financial oversight. The appointments are effective immediately, signaling a decisive move by the Supervisory Board to ensure continued leadership and growth.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Aap Implantate AG